Poplar Forest Capital LLC reduced its stake in shares of The Allstate Co. (NYSE:ALL – Free Report) by 0.7% during the 3rd quarter, HoldingsChannel reports. The fund owned 200,948 shares of the insurance provider’s stock after selling 1,496 shares during the period. Allstate accounts for 5.2% of Poplar Forest Capital LLC’s portfolio, making the stock its 3rd largest position. Poplar Forest Capital LLC’s holdings in Allstate were worth $38,110,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. Northwest Investment Counselors LLC acquired a new stake in Allstate during the 3rd quarter worth approximately $28,000. Catalyst Capital Advisors LLC acquired a new stake in Allstate during the 3rd quarter worth approximately $29,000. Versant Capital Management Inc grew its position in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares in the last quarter. Family Firm Inc. acquired a new stake in Allstate in the second quarter valued at approximately $38,000. Finally, MCF Advisors LLC grew its position in Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after acquiring an additional 84 shares in the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Allstate Stock Performance
ALL stock opened at $188.69 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market capitalization of $49.97 billion, a price-to-earnings ratio of 12.22, a PEG ratio of 1.73 and a beta of 0.48. The Allstate Co. has a 1 year low of $127.93 and a 1 year high of $198.79. The stock’s fifty day moving average is $188.89 and its two-hundred day moving average is $175.59.
Insider Buying and Selling at Allstate
In other news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is owned by insiders.
Wall Street Analyst Weigh In
ALL has been the subject of several recent research reports. Morgan Stanley increased their price objective on shares of Allstate from $202.00 to $215.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Bank of America increased their price objective on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research report on Friday, October 18th. StockNews.com downgraded shares of Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Barclays increased their price objective on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research report on Thursday, October 31st. Finally, TD Cowen increased their target price on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $209.50.
View Our Latest Stock Analysis on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- What Are Dividends? Buy the Best Dividend Stocks
- Monster Beverage Is a Scary Good Deal at Current Levels
- How to Invest in Small Cap StocksÂ
- 2 Online Educational Platforms Staging a Turnaround
- Top Stocks Investing in 5G Technology
- Top 3 Sectors Outperforming After Trump’s Victory
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.